These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 35473846
21. Prediction of nocturnal ventilation by pulmonary function testing in patients with amyotrophic lateral sclerosis. Tress F, Luecke E, Stegemann-Koniszewski S, Lux A, Singla A, Schreiber J. Pneumologie; 2024 Sep; 78(9):626-633. PubMed ID: 39079696 [Abstract] [Full Text] [Related]
22. Relationship between quantitative strength and functional outcomes in the phase 2 FORTITUDE-ALS trial. Shefner JM, Jacobsen B, Kupfer S, Malik FI, Meng L, Wei J, Wolff AA, Rudnicki SA. Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):162-169. PubMed ID: 37641579 [Abstract] [Full Text] [Related]
28. Dyspnea in amyotrophic lateral sclerosis: The Dyspnea-ALS-Scale (DALS-15) essentially contributes to the diagnosis of respiratory impairment. Vogt S, Schreiber S, Kollewe K, Körner S, Heinze HJ, Dengler R, Petri S, Vielhaber S. Respir Med; 2019 Apr 01; 154():116-121. PubMed ID: 31234039 [Abstract] [Full Text] [Related]
29. Relationships between slow vital capacity and measures of respiratory function on the ALSFRS-R. Jackson C, De Carvalho M, Genge A, Heiman-Patterson T, Shefner JM, Wei J, Wolff AA. Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov 01; 19(7-8):506-512. PubMed ID: 30379086 [Abstract] [Full Text] [Related]
37. Effects of early introduction of non-invasive positive pressure ventilation based on forced vital capacity rate of change: Variation across amyotrophic lateral sclerosis clinical phenotypes. Elamin EM, Wilson CS, Sriaroon C, Crudup B, Pothen S, Kang YC, White KT, Anderson WM. Int J Clin Pract; 2019 Jan 01; 73(1):e13257. PubMed ID: 30230161 [Abstract] [Full Text] [Related]